Researcher
Alex Crawford
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Molecular Biodiscovery (Division)
Member
From1 Apr 2013 → 30 Sep 2016
Publications
1 - 10 of 21
- The marine biodiscovery pipeline and ocean medicines of tomorrow(2016)
Authors: Alex Crawford
Pages: 151 - 158 - Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish(2015)
Authors: Peter de Witte, Alex Crawford, Camila Esguerra
Pages: 53 - 63 - ZEBRAFISH-BASED IDENTIFICATION OF APICULAREN A AS AN ANTICONVULSANT COMPOUND FROM MYXOBACTERIA(2015)
Authors: Daniëlle Copmans, J Herrmann, Annelii Ny, Yifan Zhang, G Adriaenssens, R Mueller, Peter de Witte, Alex Crawford
Pages: 44 - 44 - MODELING OF FEVER-ASSOCIATED EPILEPSY SYNDROMES CAUSED BY MUTATIONS IN STX1B IN ZEBRAFISH(2015)
Authors: Aleksandra Siekierska, J Schubert, M Langlois, P May, C Huneau, F Becker, H Muhle, Arvid Suls, JR Lemke, CGF De Kovel, et al.
Pages: 220 - 220 - DE NOVO LOSS-OF-FUNCTION MUTATIONS IN CHD2 CAUSE A FEVER-SENSITIVE MYOCLONIC EPILEPTIC ENCEPHALOPATHY SHARING FEATURES WITH DRAVET SYNDROME(2014)
Authors: A Suls, JJ Jaehn, Angela Kecskés, Y Weber, S Weckhuysen, DC Craiu, Aleksandra Siekierska, T Djemie, Tatiana Afrikanova, P Gormley, et al.
Pages: 79 - 80 - Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes(2014)
Authors: Aleksandra Siekierska, Angela Kecskés, Peter de Witte, Alex Crawford, Camila Esguerra
Pages: 1327 - 1332 - De Novo Loss-of-Function Mutations in CHD2 Cause a Fever-Sensitive Myoclonic Epileptic Encephalopathy Sharing Features with Dravet Syndrome(2013)
Authors: Angela Kecskés, Aleksandra Siekierska, Tatiana Afrikanova, Alex Crawford, Peter de Witte, Camila Esguerra
Pages: 967 - 975 - Integration of Microfractionation, qNMR and Zebrafish Screening for the In Vivo Bioassay-Guided Isolation and Quantitative Bioactivity Analysis of Natural Products(2013)
Authors: Sebastian Munck, Camila Esguerra, Peter de Witte, Alex Crawford
- Validation of the Zebrafish Pentylenetetrazol Seizure Model: Locomotor versus Electrographic Responses to Antiepileptic Drugs(2013)
Authors: Tatiana Afrikanova, Olivia Erin Buenafe, Peter de Witte, Alex Crawford, Camila Esguerra
- Optimization and Pharmacological Validation of a Leukocyte Migration Assay in Zebrafish Larvae for the Rapid In Vivo Bioactivity Analysis of Anti-Inflammatory Secondary Metabolites(2013)
Authors: Camila Esguerra, Peter de Witte, Alex Crawford
Patents
1 - 7 of 7
- Treatment of epilepsy (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy (Inventor)
- Anticonvulsant activity of bisabolene sesquiterpenoids isolated from turmeric oil (Inventor)
- Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids (Inventor)
- ANTICONVULSANT ACTIVITY OF GSK-3BETA INHIBITORS (Inventor)